A phase 2a, randomized, double-blind, placebo-controlled, multicenter study to examine safety and establish proof of concept with PHX1149 in patients with type 2 diabetes mellitus.
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Dutogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Phenomix Corporation
- 21 Sep 2007 Results presented at EASD 2007.
- 26 Jun 2007 Results data presented at the 67th Annual Scientific Sessions of the American Diabetes Association (ADA) held in Chicago, Illinois, USA in June 2007 (1027864).
- 06 Mar 2007 Results have been reported.